Correlation Between AnaptysBio and Brainstorm Cell
Can any of the company-specific risk be diversified away by investing in both AnaptysBio and Brainstorm Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AnaptysBio and Brainstorm Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AnaptysBio and Brainstorm Cell Therapeutics, you can compare the effects of market volatilities on AnaptysBio and Brainstorm Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AnaptysBio with a short position of Brainstorm Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of AnaptysBio and Brainstorm Cell.
Diversification Opportunities for AnaptysBio and Brainstorm Cell
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between AnaptysBio and Brainstorm is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding AnaptysBio and Brainstorm Cell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brainstorm Cell Ther and AnaptysBio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AnaptysBio are associated (or correlated) with Brainstorm Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brainstorm Cell Ther has no effect on the direction of AnaptysBio i.e., AnaptysBio and Brainstorm Cell go up and down completely randomly.
Pair Corralation between AnaptysBio and Brainstorm Cell
Given the investment horizon of 90 days AnaptysBio is expected to generate 0.63 times more return on investment than Brainstorm Cell. However, AnaptysBio is 1.59 times less risky than Brainstorm Cell. It trades about 0.22 of its potential returns per unit of risk. Brainstorm Cell Therapeutics is currently generating about -0.24 per unit of risk. If you would invest 2,072 in AnaptysBio on February 3, 2024 and sell it today you would earn a total of 586.00 from holding AnaptysBio or generate 28.28% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
AnaptysBio vs. Brainstorm Cell Therapeutics
Performance |
Timeline |
AnaptysBio |
Brainstorm Cell Ther |
AnaptysBio and Brainstorm Cell Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AnaptysBio and Brainstorm Cell
The main advantage of trading using opposite AnaptysBio and Brainstorm Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AnaptysBio position performs unexpectedly, Brainstorm Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainstorm Cell will offset losses from the drop in Brainstorm Cell's long position.AnaptysBio vs. Deciphera Pharmaceuticals LLC | AnaptysBio vs. Crinetics Pharmaceuticals | AnaptysBio vs. Rhythm Pharmaceuticals | AnaptysBio vs. Kura Oncology |
Brainstorm Cell vs. Protalix Biotherapeutics | Brainstorm Cell vs. Corvus Pharmaceuticals | Brainstorm Cell vs. Aldeyra | Brainstorm Cell vs. Gamida Cell |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Stocks Directory Find actively traded stocks across global markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |